NP Veny Kartika Yantie
Department Of Child Health, Faculty Of Medicine, Universitas Udayana, Integrated Cardiac Service, Sanglah Hospital, Denpasar

Published : 13 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Medicina

INHIBITOR IN HEMOPHILIA K Yantie, Veny; K, Ariawati
Medicina Vol 43 No 1 (2012): Januari 2012
Publisher : Medicina

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (761.677 KB)

Abstract

Hemophilia is an X-linked recessive disorder which is believed to affect approximately one in 5000-10.000 male birth. An inhibitor  is a type of antibody. In hemophilia patients type A, B, and C are directly destroy factor VII, IX, and XI. The incidence of antibody development in hemophilia A is between 20% and 40%, hemophilia B inhibitors only 1 to 6 %. The presence of an inhibitor is usually confirmed using a specific blood test called the Bethesda inhibitor assay. The treatment of hemophilic bleeding in a person with an inhibitor can be a challenging experience. Patients hemophilia with inhibitor have poor prognostic. (MEDICINA 2012;43:31-36).